Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: ratan lal who wrote (2766)	5/22/1998 4:45:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Ratan, I'm too busy reading all these Viagra news to have any reaction at all. <What would you do if you had 8.7 million or 1.7 million shares of PFE?> If I have 1.7 million shares, I won't be here posting!!

To: ratan lal who wrote (2766)	5/22/1998 4:49:00 PM
From: Sonki	Respond to of 9523

Ratan, today is one of those days where I just HAD to buy something. Now that i m fresh our of cash( an on margin, aginst my house policy) i remembered one of your post and for the very first time in my life i sold pfe puts to make cash. but i have NOT sold calls as u suggested. some how it's very difficult for me to sell pfe (bad sign on my side - shows attachment to the company). so the stragety u recommended several days ago is great and my comment is that you can employ this modified version by doing it over several days where u buy or sell puts on a down day and sell calls on upday. my old pfe are very deep in mony and can't afford to pay taxes but i will certainly do it with new pfe. thnks for the suggestion. it has been suggested before i tell you i am a little chicken when it comes to selling puts. only for pfe.... i will.

To: ratan lal who wrote (2766)	5/22/1998 4:53:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Pfizer Stock Swoons Amid Reports of Viagra Deaths May 22, 1998 4:27 PM NEW YORK (Dow Jones)--Pfizer Inc.'s (PFE) report that six people died while taking its Viagra impotence drug caused the company's stock to swoon Friday, even though it disclosed that deaths had occurred in clinical trials. As required by law, Pfizer alerted the Food and Drug Administration on Thursday of the six deaths, according to Ivy Kupec, a spokeswoman for the agency. Pfizer is trying to determine what caused the deaths. A spokeswoman for the New York pharmaceutical giant, Mariann Caprino, declined to provide further details. During Pfizer's year-long clinical trials of Viagra, eight of the 4,500 patients died, Caprino said. None of those deaths were attributed to Viagra itself, she said. More than 1 million men now take Viagra, which received marketing approval March 27. The company is required to report the deaths of all patients regardless of the cause, both while testing a new drug and after it hits the market. People with erectile dysfunction also frequently suffer from other serious underlying health conditions, such as diabetes or cardiovascular disease, Caprino said. Diabetes, prostate cancer and other conditions can lead to impotence. Pfizer on Thursday repeated earlier warnings that patients on nitroglycerine and related drugs shouldn't use Viagra, a caution that has been on the drug's label since its approval in March. Using the two drugs together may cause patients' blood pressure to fall to dangerous levels. News of the six deaths doesn't seem to be causing much concern. The FDA continues to believe Viagra is safe and effective for its labeled indication and intended patient population, according to Kupec. Investors sent the stock down just 3 11/16, or 3.4%, to 105 7/16, on nearly two times the stock's average daily volume of 5.1 million shares. Analysts continued to recommend purchasing Pfizer, saying Friday's decline is a buying opportunity.